Korean Journal of Biological Psychiatry (생물정신의학)
- Volume 12 Issue 2
- /
- Pages.143-150
- /
- 2005
- /
- 1225-8709(pISSN)
- /
- 2005-7571(eISSN)
Changes of Interleukin-12 and Transforming Growth Factor Beta 1 before and after Antipsychotic Treatments in Schizophrenic Patients
정신분열병 환자에서 Interleukin-12와 Transforming Growth Factor Beta 1의 치료 전후의 변화
- Kim, Sung-Jae (Department of Psychiatry, College of Medicine, Korea University, Ansan Hospital) ;
- Lee, Bun-Hee (Department of Psychiatry, College of Medicine, Korea University, Ansan Hospital) ;
- Kim, Yong-Ku (Department of Psychiatry, College of Medicine, Korea University, Ansan Hospital)
- Published : 2005.11.30
Abstract
Background:Several reports have suggested that cytokine alterations could be related to the pathophysiology of schizophrenia. In this study, we measured plasma level of interleukin-12(IL-12), a proinflammatory T helper 1(Th1) cytokine and transforming growth factor-
목 적: 많은 연구에서 정신분열병에서 염증반응체계의 활성화와 사이토카인의 변화가 병태생리학적 및 원인적 역할을 하는 것으로 보고되어 왔으며, 여기에는 type 1 Thelper cell(Th1), type 2 T helper cell(Th2), type 3 T helper cell(Th3)의 조절 이상이 제시되고 있다. 본 연구에서는 정신분열병 환자에서 항정신병 약물 치료 전후로 Th1 사이토카인인 interleukin-12(IL-12), Th3 사이토카인인 transforming growth factor-